
Sitadiet-Met 50/500 Tablet
Marketer
Johnlee Pharmaceuticals Pvt Ltd
Salt Composition
Sitagliptin (50mg) + Metformin (500mg)
Overview Sitadiet-Met 50/500 Tablet
Combiflor 50/500mg tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk (heart attack or stroke). Combiflor 50/500mg may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose levels, and concomitant medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily administration, at the same time, maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise plan is crucial for effective diabetes control. Lifestyle choices significantly impact diabetes management. Common adverse events include diarrhea, nausea, vomiting, dyspepsia, headache, and pharyngitis. Hypoglycemia is a potential risk, particularly when co-administered with insulin or sulfonylureas; understanding hypoglycemia recognition and management is essential. This medication isn't suitable for all individuals. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic disorders, or excessive alcohol consumption. Pregnant or lactating women should seek medical counsel. Interactions with other medications are possible; disclose all current medications to ensure treatment safety. Alcohol intake should be minimized due to its potential to exacerbate hypoglycemia. Your doctor will monitor renal function and blood glucose levels throughout the treatment course.
Primary Ingredients of Sitadiet-Met 50/500 Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Sitadiet-Met 50/500 Tablet
Managing type 2 diabetes
Major Benefits of Sitadiet-Met 50/500 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitadiet-Met 50/500 Tablets should be administered with a meal.
Common Side effects of Sitadiet-Met 50/500 Tablet:
- Decreased appetite
- Vomiting
- Upper respiratory tract infection
- Hypoglycemia (low blood glucose level)
- Abdominal bloating
- Nausea
- Diarrhea
How to use Sitadiet-Met 50/500 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitadiet-Met 50/500 Tablet with a meal.
How Sitadiet-Met 50/500 Tablet works:
Sitadiet-Met 50/500 tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin responsiveness. This dual action leads to superior glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Sitadiet-Met 50/500 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Sitadiet-Met 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Sitadiet-Met 50/500 Tablet use are likely incompatible. Available data in humans indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Sitadiet-Met 50/500 Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is necessary. Sitadiet-Met 50/500 Tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverUNSAFE
The use of Sitadiet-Met 50/500 Tablets is inadvisable for individuals with hepatic impairment and should be forgone. Medical advice is recommended.
What if you forget to take Sitadiet-Met 50/500 Tablet :
Should you forget a dose of Sitadiet-Met 50/500 Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sitadiet-Met 50/500 Tablet
Label | Value |
---|---|
Developing Habits | No. |
Treatment Category | Diabetes Management |